Inactivation of von Hippel-Lindau Gene Induces Constitutive Phosphorylation of MET Protein in Clear Cell Renal Carcinoma
Open Access
- 1 April 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (7) , 3699-3705
Abstract
It is well known that inactivation of von Hippel-Lindau (VHL) gene predisposes for human clear cell renal carcinoma (CCRC). However, details about critical roles of VHL inactivation during tumorigenesis are still unknown. MET protein is a tyrosine kinase receptor for hepatocyte growth factor/scatter factor (HGF/SF), which regulates cell growth, cell morphology, and cell motility. We showed that MET protein overexpressed in CCRC cells was phosphorylated without HGF/SF. This constitutive phosphorylation of MET protein in CCRC cells was inhibited by the rescue of exogenous wild-type VHL gene without a decrease in expression level of MET protein. Interestingly, wild-type VHL gene suppressed the phosphorylation of MET protein only under high cell density conditions. Additionally, MET protein activated by the inactivation of VHL gene modified cell adherence, including N-cadherin and β-catenin. When activation of MET protein in CCRC cells was inhibited by the MET inhibitor K252a, the growth of CCRC cells in vitro and the tumorigenesis induced by CCRC cells in nude mice were suppressed. From these results, we concluded that inactivation of VHL gene induced constitutive phosphorylation of MET protein and modified intercellular adherence structure to trigger the cell growth released from contact inhibition, finally resulting in tumorigenesis. This is one of the mechanisms of CCRC oncogenesis, and MET protein has potential as a molecular target for novel CCRC therapies. (Cancer Res 2006; 66(7): 3699-705)Keywords
This publication has 49 references indexed in Scilit:
- von Hippel–Lindau protein complex is regulated by cell densityOncogene, 2003
- Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through Hypoxia-inducible factorOncogene, 2003
- The Semaphorin 4D receptor controls invasive growth by coupling with MetNature Cell Biology, 2002
- VHL Induces Renal Cell Differentiation and Growth Arrest through Integration of Cell-Cell and Cell-Extracellular Matrix SignalingMolecular and Cellular Biology, 2001
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor ProteinJournal of Biological Chemistry, 2000
- The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activityGenes & Development, 1999
- BIOLOGICAL ROLE OF HGF/MET PATHWAY IN RENAL CELL CARCINOMAJournal of Urology, 1999
- C-Met Proto-Oncogene Expression in Benign and Malignant Human Renal TissuesJournal of Urology, 1997
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991